The Clinical Significance in Healthy Men of the Association Between Obesity Related Plasma Hemodilution and Tumor Marker Concentration
Authors:
- 28 February 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 181 (2) , 567-573
Abstract
We investigated the association between body mass index and the concentration of tumor markers including carcinoembryonic antigen, alpha-fetoprotein, the carbohydrate antigen 19-9 and prostate specific antigen, as well as the association between body mass index changes and tumor marker concentration changes in a population of healthy men. We evaluated data on 8,776 men screened for tumor markers (carcinoembryonic antigen, alpha-fetoprotein, carbohydrate antigen 19-9 and prostate specific antigen) at least 3 times annually during an annual examination from 2001 to 2007. We assessed the tumor marker test findings for a trend in the age, alanine aminotransferase and creatinine adjusted tumor marker concentration by body mass index. We used multivariate regression analysis to determine whether a change in body mass index was associated with a tumor marker concentration change over time using calculated tumor markers, body mass index, creatinine and alanine aminotransferase concentration change per year. After adjusting for age, creatinine and alanine aminotransferase a higher body mass index was associated with lower prostate specific antigen (p for trend <0.001), carcinoembryonic antigen (p for trend <0.001) and carbohydrate antigen 19-9 (p for trend <0.001). On multivariate regression analysis each 1 kg/m(2) of body mass index gain per year was associated with a -0.011 ng/ml change in prostate specific antigen concentration, a -0.030 ng/ml change in carcinoembryonic antigen concentration and a -0.192 IU/ml change in carbohydrate antigen 19-9 concentration per year. In this cohort of healthy men hemodilution from increased plasma volume may be responsible for the observed decreased tumor marker concentration in men with a higher body mass index. In addition, an increase in body mass index may predict a lower tumor marker concentration in an individual.Keywords
This publication has 17 references indexed in Scilit:
- Association of Obesity With Prostate Specific Antigen and Prostate Specific Antigen Velocity in Healthy Young MenJournal of Urology, 2008
- Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate CancerJAMA, 2007
- Methods of Calculating Prostate-Specific Antigen VelocityEuropean Urology, 2007
- Associations of demographic and lifestyle characteristics with prostate‐specific antigen (PSA) concentration and rate of PSA increaseCancer, 2005
- The association of body mass index and prostate‐specific antigen in a population‐based studyCancer, 2005
- Changing trends of prostate cancer in AsiaThe Aging Male, 2004
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Dietary Fat, Calories, and Prostate Cancer RiskJNCI: Journal of the National Cancer Institute, 1999
- Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction WorkersJNCI: Journal of the National Cancer Institute, 1997